{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:04:54Z","timestamp":1789088694404,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,3]],"date-time":"2013-03-03T00:00:00Z","timestamp":1362268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00251-013-0688-7","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T12:16:49Z","timestamp":1362226609000},"page":"397-403","source":"Crossref","is-referenced-by-count":8,"title":["IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test"],"prefix":"10.1007","volume":"65","author":[{"given":"Jean-Fran\u00e7ois","family":"G\u00e9linas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynold C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa H.","family":"Shoukry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,3]]},"reference":[{"key":"688_CR1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","volume":"13","author":"MJ Alter","year":"2007","unstructured":"Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436\u20132441","journal-title":"World J Gastroenterol"},{"key":"688_CR2","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.1128\/JVI.01083-08","volume":"82","author":"G Badr","year":"2008","unstructured":"Badr G, Bedard N, Abdel-Hakeem MS, Trautmann L, Willems B, Villeneuve JP, Haddad EK, Sekaly RP, Bruneau J, Shoukry NH (2008) Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J Virol 82:10017\u201310031","journal-title":"J Virol"},{"issue":"4","key":"688_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/cis915","volume":"56","author":"P Barreiro","year":"2012","unstructured":"Barreiro P, Vispo E, Poveda E, Fernandez-Montero JV, Soriano V (2012) Hepatitis C therapy\u2014highlights from EASL 2012. Clin Infect Dis 56(4):560\u2013566","journal-title":"Clin Infect Dis"},{"issue":"78\u201385","key":"688_CR4","first-page":"e2","volume":"142","author":"S Beinhardt","year":"2012","unstructured":"Beinhardt S, Aberle JH, Strasser M, Dulic-Lakovic E, Maieron A, Kreil A, Rutter K, Staettermayer AF, Datz C, Scherzer TM, Strassl R, Bischof M, Stauber R, Bodlaj G, Laferl H, Holzmann H, Steindl-Munda P, Ferenci P, Hofer H (2012) Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection. Gastroenterology 142(78\u201385):e2","journal-title":"Gastroenterology"},{"key":"688_CR5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","volume":"128","author":"L Chen","year":"2005","unstructured":"Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, Heathcote J, Edwards AM, McGilvray ID (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128:1437","journal-title":"Gastroenterology"},{"key":"688_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2008.11.049","volume":"136","author":"AL Cox","year":"2009","unstructured":"Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM (2009) Rare birds in North America: acute hepatitis C cohorts. Gastroenterology 136:26\u201331","journal-title":"Gastroenterology"},{"key":"688_CR7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.24056","volume":"53","author":"JM Darling","year":"2011","unstructured":"Darling JM, Aerssens J, Fanning G, McHutchison JG, Goldstein DB, Thompson AJ, Shianna KV, Afdhal NH, Hudson ML, Howell CD, Talloen W, Bollekens J, De Wit M, Scholliers A, Fried MW (2011) Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology 53:14\u201322","journal-title":"Hepatology"},{"key":"688_CR8","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1073\/pnas.1016358108","volume":"108","author":"MM Dring","year":"2011","unstructured":"Dring MM, Morrison MH, McSharry BP, Guinan KJ, Hagan R, O'Farrelly C, Gardiner CM (2011) Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc Natl Acad Sci U S A 108:5736\u20135741","journal-title":"Proc Natl Acad Sci U S A"},{"key":"688_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.immunol.25.022106.141602","volume":"25","author":"LB Dustin","year":"2007","unstructured":"Dustin LB, Rice CM (2007) Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 25:71\u201399","journal-title":"Annu Rev Immunol"},{"key":"688_CR10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399\u2013401","journal-title":"Nature"},{"key":"688_CR11","doi-asserted-by":"crossref","unstructured":"Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K, on behalf of the InC3 Study Group (2012) Cohort profile: the International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) study. Int J Epidemiol. doi: 10.1093\/ije\/dys167","DOI":"10.1093\/ije\/dys167"},{"key":"688_CR12","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1053\/j.gastro.2004.09.044","volume":"127","author":"EJ Heathcote","year":"2004","unstructured":"Heathcote EJ (2004) Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 127:S294\u2013S302","journal-title":"Gastroenterology"},{"key":"688_CR13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jvh.12003","volume":"19","author":"JA Holmes","year":"2012","unstructured":"Holmes JA, Desmond PV, Thompson AJ (2012) Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection? J Viral Hepat 19:677\u2013684","journal-title":"J Viral Hepat"},{"key":"688_CR14","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","volume":"36","author":"JH Hoofnagle","year":"2002","unstructured":"Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36:S21\u2013S29","journal-title":"Hepatology"},{"key":"688_CR15","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1111\/j.1365-2893.2010.01425.x","volume":"18","author":"M Lindh","year":"2011","unstructured":"Lindh M, Lagging M, Arnholm B, Eilard A, Nilsson S, Norkrans G, Soderholm J, Wahlberg T, Wejstal R, Westin J, Hellstrand K (2011) IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon\/ribavirin for chronic hepatitis C genotype 1. J Viral Hepat 18:e325\u2013e331","journal-title":"J Viral Hepat"},{"key":"688_CR16","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/hep.25575","volume":"55","author":"L Liu","year":"2012","unstructured":"Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC (2012) Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 55:1684\u20131691","journal-title":"Hepatology"},{"key":"688_CR17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2010.05.079","volume":"139","author":"A Mangia","year":"2010","unstructured":"Mangia A, Thompson AJ, Santoro R, Piazzolla V, Tillmann HL, Patel K, Shianna KV, Mottola L, Petruzzellis D, Bacca D, Carretta V, Minerva N, Goldstein DB, McHutchison JG (2010) An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response. Gastroenterology 139:821\u2013827, 827 e1","journal-title":"Gastroenterology"},{"key":"688_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","volume":"13","author":"JM Micallef","year":"2006","unstructured":"Micallef JM, Kaldor JM, Dore GJ (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13:34\u201341","journal-title":"J Viral Hepat"},{"key":"688_CR19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3109\/00365521.2011.574731","volume":"46","author":"S Nakamoto","year":"2011","unstructured":"Nakamoto S, Kanda T, Imazeki F, Wu S, Arai M, Fujiwara K, Yokosuka O (2011) Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients. Scand J Gastroenterol 46:955\u2013961","journal-title":"Scand J Gastroenterol"},{"key":"688_CR20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","volume":"45","author":"L Prokunina-Olsson","year":"2013","unstructured":"Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164\u2013171","journal-title":"Nat Genet"},{"key":"688_CR21","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1097\/QAD.0b013e3283391d6d","volume":"24","author":"NI Rallon","year":"2010","unstructured":"Rallon NI, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, Shianna KV, Vispo E, Thompson A, McHutchison J, Soriano V (2010) Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV\/hepatitis C virus-coinfected patients. AIDS 24:F23\u2013F29","journal-title":"AIDS"},{"key":"688_CR22","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","volume":"138","author":"A Rauch","year":"2010","unstructured":"Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Gunthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338\u20131345, 1345 e1-7","journal-title":"Gastroenterology"},{"key":"688_CR23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00439-010-0945-x","volume":"129","author":"MH Roy-Gagnon","year":"2011","unstructured":"Roy-Gagnon MH, Moreau C, Bherer C, St-Onge P, Sinnett D, Laprise C, Vezina H, Labuda D (2011) Genomic and genealogical investigation of the French Canadian founder population structure. Hum Genet 129:521\u2013531","journal-title":"Hum Genet"},{"key":"688_CR24","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365\u2013386","journal-title":"Methods Mol Biol"},{"key":"688_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.genom.2.1.69","volume":"2","author":"CR Scriver","year":"2001","unstructured":"Scriver CR (2001) Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2:69\u2013101","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"688_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.micro.58.030603.123836","volume":"58","author":"NH Shoukry","year":"2004","unstructured":"Shoukry NH, Cawthon AG, Walker CM (2004) Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 58:391\u2013424","journal-title":"Annu Rev Microbiol"},{"key":"688_CR27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Muller T, Bahlo M, Stewart GJ, Booth DR, George J (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100\u20131104","journal-title":"Nat Genet"},{"key":"688_CR28","doi-asserted-by":"crossref","first-page":"e1001092","DOI":"10.1371\/journal.pmed.1001092","volume":"8","author":"V Suppiah","year":"2011","unstructured":"Suppiah V, Gaudieri S, Armstrong NJ, O'Connor KS, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Dore GJ, Irving WL, Powell E, Hellard M, Riordan S, Matthews G, Sheridan D, Nattermann J, Smedile A, Muller T, Hammond E, Dunn D, Negro F, Bochud PY, Mallal S, Ahlenstiel G, Stewart GJ, George J, Booth DR, International Hepatitis CGC (2011) IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS Med 8:e1001092","journal-title":"PLoS Med"},{"key":"688_CR29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798\u2013801","journal-title":"Nature"},{"issue":"120\u20139","key":"688_CR30","first-page":"e18","volume":"139","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, Urban T, Afdhal NH, Jacobson IM, Esteban R, Poordad F, Lawitz EJ, McCone J, Shiffman ML, Galler GW, Lee WM, Reindollar R, King JW, Kwo PY, Ghalib RH, Freilich B, Nyberg LM, Zeuzem S, Poynard T, Vock DM, Pieper KS, Patel K, Tillmann HL, Noviello S, Koury K, Pedicone LD, Brass CA, Albrecht JK, Goldstein DB, McHutchison JG (2010) Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology 139(120\u20139):e18","journal-title":"Gastroenterology"},{"key":"688_CR31","doi-asserted-by":"crossref","unstructured":"Tosato G, Cohen JI (2007) Generation of Epstein\u2013Barr virus (EBV)-immortalized B cell lines. Curr Protoc Immunol Chapter 7:Unit 7.22","DOI":"10.1002\/0471142735.im0722s76"},{"key":"688_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-385032-4.00002-1","volume":"78","author":"CM Walker","year":"2010","unstructured":"Walker CM (2010) Adaptive immunity to the hepatitis C virus. Adv Virus Res 78:43\u201386","journal-title":"Adv Virus Res"}],"updated-by":[{"DOI":"10.1007\/s00251-015-0831-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000}}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-013-0688-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-013-0688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-013-0688-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T10:50:23Z","timestamp":1562755823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-013-0688-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,3]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s00251-013-0688-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00251-015-0831-8","asserted-by":"object"}]},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,3]]}}}